 Equities research analysts predict that Concert Pharmaceuticals Inc NASDAQ:CNCE will report earnings of 0.74 per share for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for Concert Pharmaceuticals earnings. The lowest EPS estimate is 0.94 and the highest is 0.67. Concert Pharmaceuticals reported earnings of 0.93 per share in the ... 